University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Translational Research Institute

TRI Study of the Month

TRI’s Allyson Cheatham, B.S.N., RN, lead study coordinator, consults with Whit Hall, M.D., the study’s UAMS principal investigator.
TRI’s Allyson Cheatham, B.S.N., RN, lead study coordinator, consults with Whit Hall, M.D., the study’s UAMS principal investigator.

UAMS Principal Investigator: Whit Hall, M.D., professor, neonatologist, UAMS College of Medicine, Department of Pediatrics

Summary: A phase 3 multi-site clinical trial comparing a symptoms-based drug treatment approach for neonatal opioid withdrawal syndrome (NOWS) with a scheduled tapering treatment.

Significance: Called OPTimize NOW, the study should determine the optimal treatment approach for newborns.

TRI Services: Regulatory and research coordinator services

Sponsor: HELP for NOWS Consortium